Company: CERO
Filing Date: 2025-06-06
Form Type: 424B3
Source: 0001213900-25-052185
Chunk: 8

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-06
Form: 424B3
Chunk 8
---
2025, by and among CERo Therapeutics Holdings, Inc., and the investors signatory thereto (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K (File No. 001-40877) filed on April 22, 2025). |
| 99.1*          |     | Press Release dated June 6, 2025.                                                                                                                                                                                                                                                |
| 104            |     | Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.                                                                                                                                                                          |
| †              |     | Certain portions of this document that constitute confidential information have been redacted pursuant to Item 601(b)(10) of Regulation S-K.                                                                                                                                     |
| *              |     | Filed herewith.                                                                                                                                                                                                                                                                  |

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: | June 6, 2025 | CERO THERAPEUTICS HOLDINGS, INC. 
 By:                              | /s/ Chris Ehrlich       |
|:------|:-------------|:---------------------------------|:------------------------|
|       |              |                                  | Chris Ehrlich           |
|       |              |                                  | Chief Executive Officer |

<div align='center'>2</div>